AUM $6.1MER 0.47%NAV $30.59Holdings 68Inception Aug 2022
Price Chart
Key Statistics
Previous Close
$31.84Day Range
$31.59$31.76
52-Week Range
$27.97$40.67
Avg Volume
1.6KDividend Yield
1.00%Expense Ratio
0.47%AUM
$6.1MShares Outstanding
159.3KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 67.21% |
| Ireland | 4.88% |
| Netherlands | 3.87% |
| South Korea | 3.23% |
| Sweden | 3.22% |
| Canada | 3.17% |
| Denmark | 2.87% |
| Australia | 2.40% |
| Japan | 2.09% |
| Switzerland | 1.90% |
| India | 1.29% |
| China | 1.20% |
| France | 1.18% |
| Israel | 0.65% |
| Other | 0.57% |
| Italy | 0.26% |
Fund Information
- Issuer
- iShares
- Types
- GrowthTechnology
- Inception Date
- Aug 24, 2022
- Exchange
- NYSE_ARCA
- Description
- The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund issued by iShares that launched on Aug 24, 2022. It currently manages $6.1M in assets under management. The fund charges an expense ratio of 0.47%. The fund holds 68 securities in its portfolio.
Top 10 holdings represent 41.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | BIIB | BIOGEN | 5.38% | 1,396 | $329K |
| 2 | EWTX | EDGEWISE THERAPEUTICS | 4.47% | 7,148 | $273K |
| 3 | NBIX | NEUROCRINE BIOSCIENCES | 4.44% | 1,981 | $271K |
| 4 | PTCT | PTC THERAPEUTICS | 4.44% | 4,446 | $271K |
| 5 | ALKS | ALKERMES | 4.39% | 6,686 | $268K |
| 6 | ARGX | ARGENX SE ADR | 4.14% | 299 | $253K |
| 7 | SRRK | SCHOLAR ROCK HOLDING | 3.70% | 5,565 | $226K |
| 8 | PRAX | PRAXIS PRECISION MEDICINES | 3.56% | 875 | $217K |
| 9 | ACAD | ACADIA PHARMACEUTICALS | 3.55% | 10,995 | $217K |
| 10 | DNTH | DIANTHUS THERAPEUTICS INC | 3.47% | 2,848 | $212K |
| 11 | SUPN | SUPERNUS PHARMACEUTICALS | 3.43% | 5,299 | $210K |
| 12 | 326030.KS | SK BIOPHARMACEUTICALS LTD | 3.22% | 3,810 | $197K |
| 13 | DYN | DYNE THERAPEUTICS | 3.17% | 12,682 | $194K |
| 14 | HLUN-B.CO | H. LUNDBECK CLASS B | 3.06% | 26,061 | $187K |
| 15 | AXGN | AXOGEN | 2.97% | 5,092 | $181K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.77% | |
| 1W | +5.19% | |
| 1M | -11.65% | |
| 3M | -16.40% | |
| 6M | -8.59% | |
| YTD | -0.87% | |
| 1Y | +8.25% | |
| 3Y | +60.36% | |
| 5Y | +28.26% |
Moving Averages
20-Day MA
$31.90
Below 20-Day MA50-Day MA
$35.76
Below 50-Day MA200-Day MA
$34.78
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$40.67
Current Price
$31.59
52-Week Low
$27.97
$27.97$40.67
Current Yield
1.00%
Annual Dividend
$0.7471
Frequency
Annualx/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 17, 2024 | $0.1011 | Dec 20, 2024 |
| Dec 20, 2023 | $0.0063 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0082 | Jun 13, 2023 |
Dividend Payments Over Time
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with IBRN:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.